Share

Hidden Steroids in Arthritis Supplements Raise Serious Adrenal Concerns

JES cover Before you reach for that arthritis supplement, take note: Over-the-counter supplements could contain surreptitious glucocorticoids, notes a new case series study published in The Journal of The Endocrine Society. The study describes 12 patients who developed Cushing syndrome (CS) and/or adrenal insufficiency (AI) after consuming commonly used supplements such as Artri King, Ardosons, and Ajo...
Share

Sriram Gubbi of NIDDK Wins Endocrine Society’s 2025 Endocrine Images Art Competition 

SGubbi headshot for ENDO 2025 “Cosmic Bubble” image features cells from a thyroid cancer subtype  Sriram Gubbi, MD, won the Endocrine Society’s 2025 Endocrine Images Art Competition with his microphotograph of follicular thyroid carcinoma cells titled “The Cosmic Bubble”.   The art competition celebrates the beauty of endocrine science as seen through the lens of a microscope. More than 30 entries...
Share

To Your “Healthspan”

Q&A with JoAnn Manson, MD, DrPH, MACP Endocrine News talks to the Endocrine Society’s 2025 Outstanding Clinical Investigator Laureate JoAnn Manson, MD, DrPH, MACP, about her ongoing research on menopausal estrogen therapy, the risks and benefits of nutritional supplements, her numerous large-scale prevention trials, and why she feels that the concept of a “healthspan” is...
Share

Health Challenges in Males with Classic Adrenal Hyperplasia

jcem_110_1cover Males diagnosed with classic congenital hyperplasia (CAH) due to 21-hydroxylase deficiency require lifelong treatment, with adolescence the most challenging treatment period, notes a review article in The Journal of Clinical Endocrinology & Metabolism and a supplement sponsored by Neurocrine Biosciences, Inc., an American biopharmaceutical company that develops for neurological and endocrine-related disorders. To replace the...
Share

Pharma Fridays – May 16, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome On May 12, Amylyx Pharmaceuticals, Inc.  announced positive Week 48 data from the Phase 2 open-label HELIOS clinical trial of AMX0035 (sodium phenylbutyrate [PB] and...
Share

Taking the Skeletons Out of the Closet

Three Studies Reveal New Insights into Osteoporosis and Bone Health A trio of studies from the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism examines several issues relating to bone health complications. These papers looked at treatment options to increase bone density in breast cancer patients; the impact of sleeve gastrectomy procedures on bone mass...
Share

Pharma Fridays – May 9, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * New OTC Weight Loss Pill Granted Patent On May 6, Olfactive Biosolutions was granted a patent for formulations of food molecules that cause significant weight loss when taken as a daily pill. The company’s Pivit supplement induces the simultaneous secretion of...